Childhood Cardiac Tumors
Cardiac Tumors in children and adolescents
TREATMENT READING
Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.
Not medical advice · Not a complete treatment or trial directory
Made by Triangle.
Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
Source: Childhood Cardiac Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Successful treatment may require surgery, debulking for progressive symptoms, cardiac transplant, and chemotherapy that is appropriate for the type of cancer.[1-3]; [4][Level of evidence C1] In one series, 95% of patients were free from cardiac tumor recurrence at 10 years.[5] A meta-analysis of 713 pediatric patients revealed a cumulative, 30-day overall mortality rate of 5.5%, with a rate of 7.5% for patients after surgery. A lower mortality rate was seen in children younger than 1 year.[6]
Treatment options for childhood cardiac tumors, according to tumor type or resectability, are as follows:
This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.
Source: Childhood Cardiac Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Most rhabdomyomas, whether diagnosed prenatally or postnatally, will spontaneously regress.[7] However, although some lesions can regress spontaneously, certain practitioners may recommend prophylactic resection to prevent mass-related complications.[5,8,9]; [10][Level of evidence C2]
Source: Childhood Cardiac Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Patients with cardiac sarcomas have a poor outcome and can be treated with multimodal therapy. The use of preoperative chemotherapy and/or radiation therapy may be of value in reducing tumor volume before surgery.
Source: Childhood Cardiac Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Source: Childhood Cardiac Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Source: Childhood Cardiac Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Information about National Cancer Institute (NCI)–supported clinical trials can be found on the NCI website. For information about clinical trials sponsored by other organizations, see the ClinicalTrials.gov website.
Sources: NCI website · ClinicalTrials.gov website
Source: Childhood Cardiac Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Cancer in children and adolescents is rare, although the overall incidence has slowly increased since 1975.[1] Children and adolescents with cancer should be referred to medical centers that have a multidisciplinary team of cancer specialists with experience treating the cancers that occur during childhood and adolescence. This multidisciplinary team approach incorporates the skills of the following pediatric specialists and others to ensure that children receive treatment, supportive care, and rehabilitation to achieve optimal survival and quality of life:
Sources: 1
Primary care physicians.
Pediatric surgeons.
Pathologists.
Pediatric radiation oncologists.
Pediatric medical oncologists and hematologists.
Ophthalmologists.
Rehabilitation specialists.
Pediatric oncology nurses.
Social workers.
Child-life professionals.
Psychologists.
Nutritionists.
For specific information about supportive care for children and adolescents with cancer, see the summaries on Supportive and Palliative Care.
Sources: Supportive and Palliative Care
The American Academy of Pediatrics has outlined guidelines for pediatric cancer centers and their role in the treatment of children and adolescents with cancer.[2] At these centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate is offered to most patients and their families. Clinical trials for children and adolescents diagnosed with cancer are generally designed to compare potentially better therapy with current standard therapy. Other types of clinical trials test novel therapies when there is no standard therapy for a cancer diagnosis. Most of the progress in identifying curative therapies for childhood cancers has been achieved through clinical trials. Information about ongoing clinical trials is available from the NCI website.
Sources: 2 · NCI website
Dramatic improvements in survival have been achieved for children and adolescents with cancer. Between 1975 and 2020, childhood cancer mortality decreased by more than 50%.[3-5] Childhood and adolescent cancer survivors require close monitoring because side effects of cancer therapy may persist or develop months or years after treatment. For information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors, see Late Effects of Treatment for Childhood Cancer.
Sources: 3 · 5 · Late Effects of Treatment for Childhood Cancer
Childhood cancer is a rare disease, with about 15,000 cases diagnosed annually in the United States in individuals younger than 20 years.[6] The U.S. Rare Diseases Act of 2002 defines a rare disease as one that affects populations smaller than 200,000 people in the United States. Therefore, all pediatric cancers are considered rare.
Sources: 6 · Rare Diseases Act of 2002
The designation of a rare tumor is not uniform among pediatric and adult groups. In adults, rare cancers are defined as those with an annual incidence of fewer than six cases per 100,000 people. They account for up to 24% of all cancers diagnosed in the European Union and about 20% of all cancers diagnosed in the United States.[7,8] In children and adolescents, the designation of a rare tumor is not uniform among international groups, as follows:
A consensus effort between the European Union Joint Action on Rare Cancers and the European Cooperative Study Group for Rare Pediatric Cancers estimated that 11% of all cancers in patients younger than 20 years could be categorized as very rare. This consensus group defined very rare cancers as those with annual incidences of fewer than two cases per 1 million people. However, three additional histologies (thyroid carcinoma, melanoma, and testicular cancer) with incidences of more than two cases per 1 million people were also included in the very rare group due to a lack of knowledge and expertise in the management of these tumors.[9]
Sources: 9
The Children's Oncology Group defines rare pediatric cancers as those listed in the International Classification of Childhood Cancer subgroup XI, which includes thyroid cancers, melanomas and nonmelanoma skin cancers, and multiple types of carcinomas (e.g., adrenocortical carcinomas, nasopharyngeal carcinomas, and most adult-type carcinomas such as breast cancers and colorectal cancers).[10] These diagnoses account for about 5% of the cancers diagnosed in children aged 0 to 14 years and about 27% of the cancers diagnosed in adolescents aged 15 to 19 years.[4] Most cancers in subgroup XI are either melanomas or thyroid cancers, with other cancer types accounting for only 2% of the cancers diagnosed in children aged 0 to 14 years and 9.3% of the cancers diagnosed in adolescents aged 15 to 19 years.
These rare cancers are extremely challenging to study because of the relatively few patients with any individual diagnosis, the predominance of rare cancers in the adolescent population, and the small number of clinical trials for adolescents with rare cancers.
Source: Childhood Heart Tumors (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 4, 2024. Captured 2026-09-09.
Source: Childhood Heart Tumors (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 4, 2024. Captured 2026-09-09.
A pediatric oncologist, a doctor who specializes in treating children with cancer, oversees treatment of heart tumors. The pediatric oncologist works with other health care providers who are experts in treating children with cancer and who specialize in certain areas of medicine. Other specialists may include:
pediatrician
Sources: pediatrician
pediatric heart surgeon
Sources: surgeon
pediatric cardiologist
Sources: cardiologist
radiation oncologist
Sources: radiation oncologist
pathologist
Sources: pathologist
pediatric nurse specialist
Sources: pediatric nurse specialist
social worker
Sources: social worker
rehabilitation specialist
Sources: rehabilitation specialist
psychologist
Sources: psychologist
child-life specialist
Sources: child-life specialist
There are different types of treatment for children and adolescents with heart tumors. You and your child's care team will work together to decide treatment. Many factors will be considered, such as your child's overall health and whether the tumor is newly diagnosed or has come back.
Your child's treatment plan will include information about the tumor, the goals of treatment, treatment options, and the possible side effects. It will be helpful to talk with your child's care team before treatment begins about what to expect. For help every step of the way, see our booklet, Children with Cancer: A Guide for Parents.
Source: Childhood Heart Tumors (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 4, 2024. Captured 2026-09-09.
Watchful waiting is closely monitoring a child's condition without giving any treatment until signs or symptoms appear or change. This treatment may be used for rhabdomyoma (a benign tumor).
Source: Childhood Heart Tumors (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 4, 2024. Captured 2026-09-09.
When possible, the tumor is removed by surgery. Types of surgery that may be done include:
Surgery to remove the tumor and some healthy tissue around it.
Heart transplant. If the child is waiting for a donated heart, they may receive other treatment as needed.
Sources: transplant
Sometimes chemotherapy may be given before surgery to make a cancerous tumor smaller and decrease the amount of tissue that needs to be removed during surgery. This is called neoadjuvant (preoperative) therapy.
Source: Childhood Heart Tumors (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 4, 2024. Captured 2026-09-09.
Chemotherapy (also called chemo) uses drugs to stop the growth of cancer cells. Chemotherapy either kills the cancer cells or stops them from dividing. For children with sarcoma, chemotherapy may be given alone or with other types of treatment to reduce the size of the tumor before surgery.
Learn more about Chemotherapy to Treat Cancer.
Sources: Chemotherapy to Treat Cancer
Source: Childhood Heart Tumors (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 4, 2024. Captured 2026-09-09.
Radiation therapy uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. Cancerous heart tumors are sometimes treated with external beam radiation therapy. External beam radiation therapy uses a machine outside the body to send radiation toward the area of the body with cancer. Radiation therapy may be used when the cancer cannot be removed by surgery.
Learn more about External Beam Radiation Therapy for Cancer and Radiation Therapy Side Effects.
Sources: External Beam Radiation Therapy for Cancer · Radiation Therapy Side Effects
Source: Childhood Heart Tumors (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 4, 2024. Captured 2026-09-09.
Targeted therapy uses drugs or other substances to block the action of specific enzymes, proteins, or other molecules involved in the growth of tumor cells.
Sources: enzymes
Targeted therapies used to treat benign heart tumors include:
everolimus
Sources: everolimus
sirolimus
Sources: sirolimus
Learn more about Targeted Therapy to Treat Cancer.
Sources: Targeted Therapy to Treat Cancer
Source: Childhood Heart Tumors (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 4, 2024. Captured 2026-09-09.
For some children, joining a clinical trial may be an option. There are different types of clinical trials for childhood cancer. For example, a treatment trial tests new treatments or new ways of using current treatments. Supportive care and palliative care trials look at ways to improve quality of life, especially for those who have side effects from cancer and its treatment.
You can use the clinical trial search to find NCI-supported cancer clinical trials accepting participants. The search allows you to filter trials based on the type of cancer, your child's age, and where the trials are being done. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website.
Sources: clinical trial search · ClinicalTrials.gov
Learn more about clinical trials, including how to find and join one, at Clinical Trials Information for Patients and Caregivers.
Sources: Clinical Trials Information for Patients and Caregivers
Source: Childhood Heart Tumors (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 4, 2024. Captured 2026-09-09.
Treatment of newly diagnosed childhood heart tumors may include:
watchful waiting for children with rhabdomyoma (a benign tumor), which sometimes shrinks and goes away on its own
Sources: watchful waiting
targeted therapy (everolimus or sirolimus) for children with rhabdomyoma or tuberous sclerosis
Sources: everolimus · sirolimus · tuberous sclerosis
chemotherapy followed by surgery (which may include removing some or all of the tumor or a heart transplant) for children with sarcomas
Sources: transplant · sarcomas
surgery to completely remove the tumor for children with other types of heart tumors
radiation therapy for children with cancerous tumors that cannot be removed by surgery
If a cancerous tumor comes back after treatment, your child's doctor will talk with you about what to expect and possible next steps. There may be treatment options that could shrink the tumor or control its growth. If there are no treatments, your child can receive care to control symptoms from cancer so they can be as comfortable as possible.
Source: Childhood Heart Tumors (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 4, 2024. Captured 2026-09-09.
Treatments for heart tumors can cause side effects. Which side effects your child might have depends on the type of treatment they receive, the dose, and how their body reacts. Talk with your child's treatment team about which side effects to look for and ways to manage them.
To learn more about side effects that begin during treatment for cancer, visit Side Effects.
Sources: side effects · Side Effects
Problems from cancer treatment that begin 6 months or later after treatment and continue for months or years are called late effects. Late effects of cancer treatment may include:
Sources: late effects
physical problems
changes in mood, feelings, thinking, learning, or memory
second cancers (new types of cancer) or other conditions
Sources: second cancers
Some late effects may be treated or controlled. It is important to talk with your child's doctors about the possible late effects caused by some treatments. Learn more about Late Effects of Treatment for Childhood Cancer.
Cardiac Tumors in children and adolescents
Unresectable Tumors